Concepedia

Cecelia P. Kane

CP

6

Publications

440

Citations

6

H-Index

2000

Active since

Affiliations

Pfizer (United States)(Current)

University of Virginia

University of Pennsylvania

University of Kansas

McMaster University

Cecelia P. Kane is an author at Pfizer (United States) specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

2000–2013

6

Publications

6

Placebo-Controlled Study of Fluvoxamine in the Treatment of Patients With Compulsive Buying

Philip T. Ninan, Susan L. McElroy, Cecelia P. Kane et al. · Journal of Clinical Psychopharmacology · 2000 · 173 citations

Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression

Sheldon Preskorn, Cecelia P. Kane, Kasia Lobello et al. · The Journal of Clinical Psychiatry · 2013 · 108 citations

Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers

Alice I. Nichols, Kristen Focht, Qin Jiang et al. · Clinical Drug Investigation · 2011 · 63 citations

, , +6

Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder

Cláudio N. Soares, Michael E. Thase, Anita H. Clayton et al. · Menopause The Journal of The North American Menopause Society · 2010 · 57 citations

Metabolism Studies of Desvenlafaxine

William DeMaio, Cecelia P. Kane, Alice I. Nichols et al. · Journal of Bioequivalence & Bioavailability · 2011 · 25 citations · Full text

Rows per page

1–5 of 6